Edward Kim, MD
Associate Professor
Locations of Practice
UW Medical Center – Montlake – Radiation Oncology Center
1959 NE Pacific Street
Seattle, WA 98195
Fred Hutchinson Cancer Center – Proton Therapy
1570 N. 115th Street
Seattle, WA 98133
https://www.fredhutch.org/en/patient-care/treatments/proton-therapy.html
Fred Hutchinson Cancer Center – South Lake Union
1354 Aloha Street
Seattle, WA 98109
Overview
Dr. Kim is a radiation oncologist who specializes in the treatment of gastrointestinal cancers, sarcoma, intraoperative radiotherapy, and intravascular brachytherapy. Dr. Kim is the University of Washington Department of Radiation Oncology program and disease site lead for gastrointestinal cancers. He is also the Medical Director for the Radiation Oncology Department at the UW Medical Center. Dr. Kim practices at UWMC, Fred Hutchinson Cancer Center – South Lake Union, and Fred Hutchinson Cancer Center – Proton Therapy.
Patient Care Philosophy
“I believe in individualized care and making decisions with my patients as a partnership.”
Education and Training
College: Case Western Reserve University, Cleveland, OH, 1998
Medical Education: Case Western Reserve University School of Medicine, Cleveland, OH, 2001
Internship: University Hospitals of Cleveland Internal Medicine, Cleveland, OH, 2002
Residency: Case Comprehensive Cancer Center, Cleveland, OH, 2007
Selected Publications from a Total of 31
Wootton L, Meyer J, Kim E, Phillips M. Commissioning, clinical implementation, and performance of the Mobetron 2000 for intraoperative radiation therapy. J Appl Clin Med Phys 2017, 230-42
Chvestov A, Rajendran J, Zeng J, Patel S, Bowen S, Kim E, Theoretical effectiveness of cell survival during fractionated radiotherapy with hypoxia-targeted dose escalation, Med Phys 2017, In Press
Richard P, Phillips M, Smith W, Davidson D, Kim E, Kane G, Cost-Effectiveness Analysis of Intensity Modulated Radiation Therapy Versus 3-Dimensional Conformal Radiation Therapy for Preoperative Treatment of Extremity Soft Tissue Sarcomas. Int J Radiat Oncol Biol Phys. 2016 Jul 1;95(3):999-1008
Lo S, Ryu S, Chang E, Galanapoulos N, Jones J, Kim E, Kubicky C, Lee C, Rose P, Sahgal A, Sloan A, The B, Traughber B, Van Poznak C, Vassil A. ACR Appropriateness Criteria Metastatic Epidural Spinal Cord Compression and Recurrent Spinal Metastasis. J Palliat Med 2015, 18(7),
Kim EY, Chapman TR, Ryu S, Chang EL, Galanopoulos N, Jones J, Kubicky CD, Lee CP, Teh BS, Traughber BJ, Van Poznak C, Vassil AD, Weber K, Lo SS.. ACR Appropriateness Criteria(®) non-spine bone metastases. J Palliat Med. 2015 Jan;18(1):11-7
Thomas TO, Hasan S, Small W Jr, Herman JM, Lock M, Kim EY, Mayr NA, Teh BS, Lo SS. The tolerance of gastrointestinal organs to stereotactic body radiation therapy: what do we know so far? J Gastrointest Oncol. 2014 Jun;5(3):236-46.
Lo S, Lutz ST, Chang RL, Galanopoulos N, Howell D, Kim EY, Konski A, Pandit-Taskar N, Rose P, Ryu S, Silverman L, Sloan A, Van Poznak C. ACR Appropriateness Criteria Spinal Bone Metastases. J Palliat Med 2013, 16(1), 1-11
Guiou M, Mayr N, Kim E, Williams T, Lo S. Stereotactic body radiotherapy for adrenal metastases from lung cancer. J Radiat Oncol 2012, 1:155-63.
Lutz EP, Lo SS, Chang EL, Galanopoulos N, Howell DD, Kim EY, Konski AA, Pandit-Taskar ND, Ryu S, Silverman LN, Van Poznak C, Weber KL. ACR Appropriateness Criteria® Non-Spine Bone Metastases. J Palliat Med. 2012 May;15(5):521-6.
Chen WC, Kim J, Kim E, Silverman P, Overmoyer B, Cooper BW, Anthony S, Shenk R, Leeming R, Hanks SH, Lyons JA. A Phase II Study of Radiotherapy and Concurrent Paclitaxel Chemotherapy in Breast-Conserving Treatment for Node-Positive Breast Cancer., Int J Radiat Oncol Biol Phys. 2012 Jan, 82(1): 14-20